Solenopsin a, b and analogs and as novel angiogenesis inhibitors
申请人:Bowen Phillip J.
公开号:US20050038071A1
公开(公告)日:2005-02-17
The present invention relates to solenopsin A and its analogs for use as angiogenesis inhibitors. The present compounds unexpectedly exhibit good activity as angiogenesis inhibitors, which find use as antitumor/anticancer agents as well as to treat a number of conditions or disease states in which angiogenesis is a factor.
[EN] SOLENOPSIN A, B AND ANALOGS AS NOVEL ANGIOGENESIS INHIBITORS<br/>[FR] SOLENOPSINE A, B ET ANALOGUES UTILISES COMME NOUVEAUX INHIBITEURS DE L'ANGIOGENESE
申请人:UNIV GEORGIA RES FOUND
公开号:WO2003061598A2
公开(公告)日:2003-07-31
The present invention relates to solenopsin A and its analogs for use as angiogenesis inhibitors. The present compounds unexpectedly exhibit good activity as angiogenesis inhibitors, which find use as antitumor/anticancer agents as well as to treat a number of conditions or disease states in which angiogenesis is a factor.
Gallium(III) Chloride-catalyzed Sakurai Reaction of α-Amido Sulfones with Allyltrimethylsilane: Access to Synthesis of 2,6-Disubstituted Piperidine Alkaloid Derivatives
of N-alkoxycarbonylamino sulfones (α-amidosulfones) with allyltrimethylsilane in the presence of gallium(III) chloride (5 mol %) proceeded smoothly to afford the corresponding protected homoallylamines in high yields (82―96%). As an application of this methodology, two-step synthesis of biologically active natural products, 2,6-disubstituted piperidine alkaloid derivatives was carried out.